Phytochemical and Anti-epileptic Studies of Ethanol Extract of Boswellia dalzielii (Frankincense Tree) Stem Bark

Main Article Content

Asinamai Ndai Medugu
James Yakubu
Usiju Ndai Medugu
Hussaini Isa Marte
Fave Yohanna Tata
Victor Musa Balami

Abstract

Aim: This research work aimed to establish scientific basis for the use of Boswellia dalzielli stem bark, in traditional medicine as anti-epileptic medication.

Methodology: The fresh stem bark of Boswellia dalzielii was extracted using absolute ethanol and screened for phytochemicals. Acute toxicity study was carried out using Lorke’s method and the antiepileptic activity was evaluated using maximal electroshock induced seizure test in day-old broiler chicks and pentylenetetrazole (PTZ) using Wistar strain mice.

Results: Phytochemical screening of ethanol extract of B. dalzielii stem bark revealed that the presence of saponins, tannins, flavonoids and steroids/terpenoides. The intrapertoneal median lethal dose value (LD50) of BDE in mice was 2592.3 mg/kg, indicating the stem bark extract is relatively safe. The extract at the dose of 500 mg/kg body weight protected 40% of animals against PTZ-induced convulsion and also protected 20% of chicks against Tonic Hindlimb Extension (THLE) phase of the Maximal Electroshock Test (MEST) significantly (p<0.05).

Conclusion: The antiepileptic investigation suggests that ethanol extract of B. dalzielii stem bark has antiepileptic activity.

Keywords:
B. dalzielii, phytochemical antiepileptic, pentylenetetrazole (PTZ), maximal electroshock induced seizure (MEST).

Article Details

How to Cite
Medugu, A. N., Yakubu, J., Medugu, U. N., Marte, H. I., Tata, F. Y., & Balami, V. M. (2020). Phytochemical and Anti-epileptic Studies of Ethanol Extract of Boswellia dalzielii (Frankincense Tree) Stem Bark. European Journal of Medicinal Plants, 31(8), 94-100. https://doi.org/10.9734/ejmp/2020/v31i830262
Section
Original Research Article

References

Bell GS, Sander JN. The epidemiology of epilepsy: The size of the problem. Seizure. 2001;10:360-310.

McNamara DJ. Pharmacotherapy of epilepsies. In: Brunton, L.L., Lazo, S.J. and Parker, K.L (Eds) Gooman and Gilman’s. The pharmacological basis of therapeutics, Eleventh Edition. McGraw-Hill Medical Publishing Division, New York. 2006;501-525.

Schmidt D. The clinical impact of new antiepileptic drugs after a decade of use in epilepsy research. 2002;50:21-32.

WHO. Epilepsy: Etiology, epidemiology; 2017.
Available:http://www.whoint>media centre>Fact sheet No. 999
(Accessed 12 December 2018)

Loscher W. Basic pharmacology of valproate: A review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs. 2002;16:669-694.

Chindo BA, Ya'u J, Danjuma NM, Okhale SE, Gamaniel KS, Becker A. Behavioral and anticonvulsant effects of the standardized extract of Ficus platyphylla stem bark. J Ethnopharmacol. 2014;154: 351-360.

Burkill HM. Useful plants of west tropical Africa. Volume One, Royal Botanical Gardens Kew. 1985;300.

Danlami U, Daniel GJ, David BM, Galadanchi KM. Phytochemical, nutritional and antimicrobial screening of hexane, ethyl acetate and ethanolic extracts of Boswellia dalzielii leaves and bark. Am J Biosci Bioeng. 2015;3(5):76-79.

Shinkafi TS, Bello L, Hassan SW, Ali L. An ethnobotanical survey of antidiabetic plants used by Hausa–Fulani tribes in Sokoto, Northwest Nigeria. J. Ethnopharmacol. 2015;172:91–99.

Ibrahim JA, Muazzam I, Jegede IA, Kunle OF, Okogun JI. Ethnomedicinal plants and methods used by Gwandara tribe of Sabo Wuse in Niger State, Nigeria to treat mental illness. Afr. J. Trad. Complement. Altern. Med. 2007;4:211–218.

Evans WC. Trease and Evans pharmacognosy. 16th Edition. Saunders Publishers, London. 2009;42–229.

Lorke W. A new approach to practical acute toxicity testing. Arch. Toxicol. 1983;54:275-287.

Swinyard EA, Woodhead JH, White HS, Franklin MR. General principles; Experimental selection, quantification and evaluation of anticonvulsant. In: Levey RH, Mattson BJK, Melrum FE, Dreifuss, (Eds) Anti-Epileptic Drugs 3rd Edition. Raven Press. New York. 1989;85-103.

Sayyah MG, Sarouvhani A, Peirovi M, Kamalineja D. Analgesic and anti-inflammatory activity of the leaf essential oil of Lavraus nobilis Linn. Phytother. Res. 2002;17:733-736.

Nwinyi FC, Binda L, Ajoku GA, Aniagu, Orisadipo NMA, Kubmarawa D, Gamaniel KS. Evaluation of the aqueous extract of B. dalzielii stem bark for antimicrobial activities and gastrointestinal effects. Afr. J. Biotech. 2004;3(5):284-288.

Mamza UT, Sodipo OA, Abdulrahman FI, Khan IZ. Phytochemical analysis and in vitro antimicrobial assay of the methanolic stem bark extract of Boswellia dalzielii Hutch. (Burseraceae). Chem. Res. J. 2018;3(4):61-168.

Ya'u J, Yaro AH, Malami S, Musa MA, Abubakar A, Yahaya SA, Chindo BA, Anuka JA, Hussaini IM. Anticonvulsant activity of aqueous fraction of Carissa edulis root bark. Pharmaceut. Biol. 2015;53(9):1329-1338.

Wapa KL, Nazifi AB, Malami S. Evaluation of anticonvulsant activity of methanol leaf extract of Peristrophe bicalyculata (Acanthaceae) in experimental animals. Nig. J. Pharmaceut. Biomed. Res. 2018;3(2):89-95.

Dubois M, Ilyas M, Wagner H. Cussonosides A and B, two Triterpene saponins-Saponin from Cussonia bateri. Planta Med. 1986;52(2):80–83.

Singh HK, Rastogi RP, Srimal RC, Dhawan BN. Effect of bacoside A and B on theavoidance responses in rats. Phytother Res. 1988;2:70–5.

Kavvadias D, Sand P, Youdim KA, Rice-Evans C, Baor R, Siegel E, Rausch WF, Riederer P, Schreirer P. The flavones hispidulin, a benzodiazepine receptor Ligand with positive allosterric properties, Transverses the blood brain barrier and exhibits an anticonvulsant effects. Brit. J. Pharmacol. 2004;142:811-820.

Clarke EGC, Clarke ML. Veterinary toxicology, 2nd Ed. Bailliere Tindall, New York. 1977;10.

Idris M, Abdulrahman FI, Tijjani MA, Sandabe UK. Effects of ethanol leaf extract of Terminalia avicennoides Guill and Perr. on the central and peripheral nervous system. Int J Phytopharm Res. 2017;5(4):178-183.

Woo SW, Kuk HS, Sam SK. Chemistry and pharmacology of flavones-C glycosides from ziziphus seeds. Korean J. Pharm. 1980;11:141-148.

Loscher W, Honack D, Fassbender CP, Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. Pentylenetetrazole seizure model. Epilepsy Res. 1991;8:171-189.

White HS, Wolf HH, Woodhead HJ, Kupferberg HJ. The National Institute of health anticonvulsant drugs development programme. Screening for efficacy. In: French J, Leppick IE, Dichtes MA, (Eds). Antiepileptic Drug Development: Advances in Neurology, Lippincott-Raven Publishers, Philadelphia. 1998;76:29-39.

Desarro A, Cecchetti V, Fravolini V, Naccari F, Tabarrini D, Desarro G. Effects of novel 6-desfluoroquinolones and classic quinolones on pentylenetetrazole-induced seizures in mice. Antimicro. Agents Chemother. 1999;43:1729-1736.

Westmoreland BF, Benarroch EE, Dube JR, Regan TJ, Sandok BA. Rochester: Mayo Foundation, Med. Neurosci. 1994;307.

Rho JM, Sankar R. The pharmacologic basic of antiepileptic drug action. Epileptic. 1999;40:1471-1483.

Meldrum BS. Update on the mechanism of action of antiepileptic drugs. Epilepsia. 1996;37(Suppl. 6):54-511.

Delorenzo RJ, Raza M, Chaudhary MI, Soria AA, Sombati S. Anticonvulsant activities of the F.S-1 subfraction isolated from roots of Delphinium denadatum. Phytother. Res. 2001;15:426-430.

Stables JP, Kupferberg HJ. The NIH Anticonvulsant Drug Development (ADD) program. In: Avanzini G, Regesta G, Tanganelli, Avoli M, (Eds). Molecular and cellular target for anti-epileptic drug. John Libbey and Company Ltd., USA. 1997;191-198.

Browning B. The electroshock model neuronal network and antiepileptic drugs. In: Faingold CL, Fromm GH, (Eds). Drugs for Control of Epilepsy: Actions on Neuronal Networks in Seizures Disorders, CRC Press, Bocca Raton, FL. 1992;195-211.